Drug resistance in epilepsy: Why is a simple explanation not enough? [2]

Epilepsia

Volumn 48, Issue 12, 2007, Pages 2370-2372

  Löscher, Wolfgang ^a,b,c   Sills, Graeme J ^d  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

^c Epilepsy Unit   (Germany)

^d WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; GLYCOPROTEIN P; LAMOTRIGINE; MULTIDRUG RESISTANCE PROTEIN; NEUROTRANSMITTER; NEUROTRANSMITTER RECEPTOR; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; XENOBIOTIC AGENT;

BLOOD BRAIN BARRIER; CONCENTRATION (PARAMETERS); DRUG PENETRATION; EPILEPSY; EXON; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; LETTER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ANTICONVULSANTS; DRUG RESISTANCE; EPILEPSY; EXONS; GENES, MDR; HUMANS; P-GLYCOPROTEIN; P-GLYCOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RODENTIA; VARIATION (GENETICS);

EID: 36949040830     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2007.01260_2.x     Document Type: Letter

References (13)

1. Baltes S, Fedrowitz M, Luna Tortós C, Potschka H, Löscher W 2007a) Valproic acid is not a substrate for P-glycoprotein or multidrug resistance proteins 1 and 2 in a number of in vitro and in vivo transport assays. J Pharmacol Exp Ther 320 : 331 343.
2. Baltes S, Gastens AM, Fedrowitz M, Potschka H, Kaever V, Loscher W 2007b) Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein. Neuropharmacology 52 : 333 346.
3. Crowe A, Teoh Y-K 2006) Limited P-glycoprotein mediated efflux for anti-epileptic drugs. J Drug Targeting 14 : 291 300.
4. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U 2000) Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 97 : 3473 3478.
5. Kimchi-Sarfaty C, Oh JM, Kim I-W, Sauna ZE, Calcagno AM, Ambudkar SV, Gottesman MM 2007) A 'silent' polymorphism in the MDR1 gene changes substrate specificity. Science 315 : 525 528.
6. Kwan P, Brodie MJ 2005) Potential role of drug transporters in the pathogenesis of medically intractable epilepsy. Epilepsia 46 : 224 235.
7. Löscher W, Potschka H 2005) Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 6 : 591 602.
8. Schmidt D, Löscher W 2005) Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. Epilepsia 46 : 858 877.
9. Siddiqui A, Kerb R, Weale ME, Brinkmann U, Smith A, Goldstein DB, Wood NW, Sisodiya SM 2003) Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. New Engl J Med 348 : 1442 1448.
10. Sills GJ, Mohanraj R, Butler E, McCrindle S, Collier L, Wilson EA, Brodie MJ 2005) Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment. Epilepsia 46 : 643 647.
11. Sisodiya SM, Lin W-R, Harding BN, Squier MV, Thom M 2002) Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain 125 : 22 31.
12. Sisodiya SM, Goldstein DB 2007) Drug resistance in epilepsy: more twists in the tale. Epilepsia in press.
13. Tan NCK, Heron SE, Scheffer IE, Pelekanos JT, McMahon JM, Vears DF, Mulley JC, Berkovic SF 2004) Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy. Neurology 63 : 1090 1092.